Acetylon Pharmaceuticals Revenue

Pharmaceutical Manufacturing • United States • 1-10 Employees

Acetylon Pharmaceuticals revenue & valuation

Annual revenue	$6,200,000
Revenue per employee	$2,067,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$19,900,000
Total funding	$100,000,000

Key Contact at Acetylon Pharmaceuticals

Min Yang

director of biomarker development

Company overview

Headquarters	United States
Phone number	+16172451300
Website	acetylon.com
NAICS	3254
SIC	283
Employees	1-10
Socials

About Acetylon Pharmaceuticals

Acetylon Pharmaceuticals is pursuing development of next-generation, selective histone deacetylase (HDAC) enzyme inhibitors with potential for treatment of hematologic and solid tumor cancers, inflammatory diseases such as rheumatoid arthritis, neurodegenerative diseases such as Parkinson's, genetic diseases incluidng sickle cell disease and thalassemia major, and infectious disease such as malaria. Acetylon's technology is being licensed from Harvard University and the Dana Farber Cancer Center. Acetylon raised $7.25M in a Series A finanicng involving private investors including The Kraft Group in July 2009.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Employees by Department

Acetylon Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Acetylon Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2013-08-29	11	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Acetylon Pharmaceuticals is located in US.

You can reach Acetylon Pharmaceuticals at +16172451300.

Acetylon Pharmaceuticals generates an estimated annual revenue of $6,200,000. This revenue figure reflects the company's market position and business performance in its industry.

Acetylon Pharmaceuticals has an estimated valuation of $19,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Acetylon Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Acetylon Pharmaceuticals has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Acetylon Pharmaceuticals

Min Yang

director of biomarker development

4.8

40,000 users